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Introduction and objectives. To investigate the prevalence, causes and outcome of catheterization laboratory false 
alarms (CLFAs) in a regional primary angioplasty network. 
Methods. A prospective registry of 1,662 patients referred for primary angioplasty between January 2003 and August 
2008 was reviewed to identify CLFAs (i.e. when no culprit coronary lesion could be found). 
Results. No culprit coronary lesion could be identified in 120 patients (7.2%; 95% confidence interval [CI], 5.9- 
8.5%). Of these, 104 (6.3%, 95% CI, 5.1-7.4%) had a discharge diagnosis other than ST-elevation myocardial 
infarction, 91 (5.5%; 95% CI, 4.3-6.6%) had no significant coronary disease, and 64 (3.8%; 95% CI, 2.9-4.8%) tested 
negative for cardiac biomarkers. The most frequent alternative diagnoses were: previous Q-wave myocardial 
infarction (18 cases), nonspecific ST-segment abnormalities (11), pericarditis (10) and transient apical dyskinesia 
(10). The 30-day mortality rate was similar in patients with and without culprit lesions (5.8% vs. 5.8%; P=.99). The 
prevalence of CLFAs was slightly higher in patients not previously evaluated by a cardiologist and referred from 
emergency departments in hospitals without catheterization laboratories than in those referred by cardiologists from 
emergency departments at hospitals with such facilities (9.5% vs. 6.1%; P=.02; odds ratio=1.64; 95% CI, 1.08-2.5). 
The prevalence of CLFAs was not significantly higher in patients referred by physicians with out-of-hospital 
emergency medical services (7.2%; P=.51; odds ratio=1.37; 95% CI, 0.79-2.37). 
Conclusions. The prevalence of CLFAs was 7.2%, with the criterion of no culprit coronary lesion. Our findings 
suggest that different patterns of referral to catheterization laboratories could account for small variations in the 
prevalence of CLFAs. 
Introducción y objetivos. Determinar prevalencia, causas y pronóstico de las «falsas alarmas» al laboratorio de 
hemodinámica (FALH) en una red regional de angioplastia primaria. 
Métodos. Registro prospectivo de 1.662 pacientes remitidos para angioplastia primaria entre enero de 2003 y agosto 
de 2008. Se definió FALH como ausencia de lesión coronaria causal. 
Resultados. En 120 pacientes (7,2%; intervalo de confianza [IC] del 95%, 5,9-8,5) no se identificó ninguna lesión 
coronaria causal. De ellos, 104 (6,3%; IC del 95%, 5,1-7,4) recibieron un diagnóstico alternativo a IAMCEST, 91 
(5,5%; IC del 95%, 4,3-6,6) no presentaron enfermedad coronaria significativa y 64 (3,8%; IC del 95%, 2,9-4,8) 
presentaron marcadores de daño miocárdico negativos. Los diagnósticos alternativos más frecuentes fueron: infarto 
con onda Q previo (18 casos), alteraciones inespecíficas del segmento ST (11), pericarditis (10) y discinesia apical 
transitoria (10). La mortalidad a 30 días fue similar en los pacientes con y sin lesión causal (el 5,8 frente al 5,8%; 
p = 0,99). La prevalencia de FALH fue discretamente superior entre los pacientes remitidos desde los servicios de 
urgencias de hospitales no intervencionistas sin evaluación previa por un cardiólogo que entre los remitidos por 
cardiólogos desde el servicio de urgencias del hospital intervencionista (el 9,5 frente al 6,1%; p = 0,02; odds ratio 
[OR] = 1,64; IC del 95%, 1,08-2,5). No observamos un exceso de FALH entre los pacientes remitidos por médicos de 
UVI Móviles-061 (7,2%; p = 0,51; OR = 1,37; IC del 95%, 0,79-2,37). 
Conclusiones. Hemos observado una prevalencia de FALH del 7,2% de acuerdo con el criterio de ausencia de lesión 
coronaria causal. Nuestros resultados indican que diferentes modelos de activación del laboratorio de hemodinámica 
podrían justificar discretas variaciones en la prevalencia de FALH. 
  
Key words: Myocardial infarction; Angioplasty; Diagnosis; Coronary angiography 
Palabras clave: Infarto de miocardio; Angioplastia; Diagnóstico; Coronariografía 
Abbreviations: CHUAC, Complejo Hospitalario Universitario de A Coruña; CLFA, catheterization laboratory “false 
alarm”; STEMI, ST elevation myocardial infarction; OHES-061, Out-of-Hospital Emergency Service-061 
Introduction 
At the present time, primary angioplasty is the treatment of choice for patients with ST elevation 
myocardial infarction (STEMI).1 Given that the clinical benefits of the procedure depend to a large extent 
on the door-to-balloon time,2 the rapid recognition of the electrocardiographic findings that indicate 
STEMI and the immediate activation of the catheterization laboratory are of crucial importance in these 
patients. However, the confusion of the diagnosis with that of other entities that involve elevation of the 
ST segment can lead to an unnecessary emergency coronary angiography, a circumstance that increases 
health care costs and exposes the patient to the risks of the procedure.3 
The prevalence of catheterization laboratory “false alarms” (CLFA) has been proposed as an indicator 
of the quality of primary angioplasty programs,4 complementary to other parameters such as door-to-
balloon time or mortality. Moreover, the study of the causes of CLFA provides useful information for the 
design of improvements in the process of candidate selection. In previous studies, the prevalence of 
CLFA ranged between 2.3% and 14%,5-7 but there is little data concerning the influence on this indicator 
of different strategies for prehospital diagnosis and activation of the catheterization laboratory.  
Our objective is to analyze the prevalence, causes and outcome of CLFA within the framework of a 
regional primary angioplasty network and to compare the prevalence of CLFA among 3 different models 
of catheterization laboratory activation. 
Methods 
Study Context and Description 
The Interventional Cardiology Unit of Complejo Hospitalario Universitario de A Coruña (CHUAC) in 
northwestern Spain provides 24-hour primary angioplasty service for a population of nearly one million 
inhabitants, which is distributed throughout the entire Northern Area of Galicia. In this referral area, there 
are 4 hospitals that lack catheterization laboratories, which customarily refer patients to CHUAC for the 
performance of primary angioplasty.In the present article, we present an analysis of the prevalence, 
causes and outcome of the CLFA in the health care network of the Northern Area of Galicia during the 
period from January 2003 to August 2008. The information was obtained from a prospective general 
registry in which individual electronic data sheets were employed for the collection of demographic and 
clinical data, as well as information relative to the care of and complementary tests performed in all the 
patients referred to our center for primary angioplasty. The data concerning the vital status of patients 30 
days after the procedure was obtained from the follow-up registry of the Galician health care system. All 
patients gave their informed consent. 
Protocol 
In our referral area, primary angioplasty is the reperfusion therapy recommended for all patients that 
come to any service of the health care system with symptoms of myocardial ischemia developing within 
the previous 12 hours and ST segment elevation greater than 1 mm in 2 contiguous leads or a new left 
bundle branch block if, in addition, one or more of the following criteria are present at the time of 
diagnosis: foreseeable delay to angioplasty <110 minutes, time from onset of infarction >3 hours, 
cardiogenic shock, or contraindication for fibrinolysis. The physician who establishes the diagnosis of 
STEMI activates the catheterization laboratory by means of direct telephone contact with the 
interventional cardiologist on call, who decides whether or not the procedure should be performed on the 
basis of the expected benefits and the comorbidity of the patient, without reviewing the 
electrocardiogram. During the study period, no diagnostic coronary angiography was cancelled due to 
reinterpretation of the electrocardiographic findings following the arrival of the patients to the 
catheterization laboratory. 
  
Strategies for Activating the Catheterization Laboratory 
All the patients with suspected STEMI examined in the Emergency Service of CHUAC are immediately 
evaluated by the clinical cardiologist on call, who activates the catheterization laboratory once the 
diagnosis is confirmed. In uncertain cases, the cardiologist can perform a transthoracic or transesophageal 
echocardiogram if he or she considers it necessary. 
In the case of the patients diagnosed as having STEMI in the emergency services of hospitals without 
catheterization laboratories, the responsible physician (generally the family medicine or intensive care 
specialist) is in charge of activating the interventional team without consulting previously with a clinical 
cardiologist. Then, the patient is transferred by medically equipped ambulance to the Catheterization 
Laboratory of CHUAC with no previous stop in the Emergency Room of the hospital. 
As of May 2005, the physicians of the mobile intensive care unit of the Out-of-hospital Emergency 
Service 061 (OHES-061) can also activate the interventional team from any point of the referral area, and 
can then proceed with direct transfer of the patients with suspected STEMI to the CHUAC catheterization 
laboratory without stopping previously at any emergency room. All of the physicians in these units are 
specialists in family medicine or intensive care. Our protocol does not include the activation of the 
catheterization laboratory by health care technicians and, thus, all patients attended to in the out-of-
hospital setting by ambulances other than mobile intensive care units of the OHES-061 are taken to the 
closest emergency service. 
Diagnostic Coronary Angiography 
All of the coronary angiographies were performed and evaluated by interventional cardiologists with 
recognized experience. The principal operator was responsible for determining the existence of significant 
coronary artery disease and identifying the coronary lesion that caused the STEMI. Significant coronary 
artery disease, according to visual estimation, was defined as the presence of at least one coronary 
stenosis occupying >70% in at least 1 epicardial coronary artery (>50% in left main coronary artery). A 
culprit coronary lesion was defined as a total or subtotal occlusion or a stenosis >70% (>50% in left main 
coronary artery) with a visible thrombus or other characteristics that indicated acute plaque rupture in the 
artery in which the STEMI had originated. Aortic angiography and left ventriculography were performed 
systematically in those patients in whom it was not possible to identify any culprit coronary lesion. 
Definition of a Catheterization Laboratory “False Alarm”  
A CLFA was defined as the impossibility of identifying any coronary lesion as the cause of the STEMI in 
the reference coronary angiography. The retrospective diagnoses were collected from the discharge 
reports and were confirmed by 2 expert cardiologists (JMVR, EBC) following an exhaustive review of 
the clinical records. For this purpose, the diagnostic criteria proposed by Larson et al5 were employed. A 
positive test for the markers of myocardial injury was defined as the presence of a troponin I peak >0.2 
ng/mL or a creatine kinase MB fraction (CK-MB) >7%. 
Statistical Analysis 
Continuous variables are presented as means (standard deviation) and the categorical variables as absolute 
frequencies (percentages). We have employed the χ2test for the comparison of categorical variables and 
Student t test or ANOVA for the comparison of continuous variables. Owing to their deviation from a 
normal distribution, demonstrated using the Shapiro-Wilk test and P-P plots, the variables relative to 
delays in time are presented as the median [interquartile range] and are compared with the Mann-Whitney 
or Kruskal-Wallis nonparametric test. The clinical factors associated with the absence of a culprit 
coronary artery lesion were identified by means of backward stepwise logistic regression analysis (p-out 
criterion, P>.1). The candidate variables were selected according to clinical experience and the previous 
literature: female sex, age <45 years, previous myocardial infarction, previous percutaneous coronary 
intervention, previous coronary artery surgery, absence of major cardiovascular risk factors, 
hemodynamic instability, left bundle branch block, and the catheterization laboratory activation model. 
The validity of the final model was analyzed using the test for the general significance of the coefficients, 
with the Hosmer-Lemeshow goodness-of-fit test and with the construction of the receiver operating 
characteristic (ROC) curve of the logistic regression equation. The threshold for statistical significance 
was set at P<.05. All the analyses were carried out using SPSS 13.0. 
  
Results 
Between January 2003 and August 2008, 1662 patients with suspected STEMI were referred to the 
catheterization laboratory of CHUAC for the performance of primary angioplasty. Of these, 948 (57%) 
were sent from the emergency service of that same hospital (ES-CHUAC group), 451 (27.1%) came from 
the emergency services of hospitals lacking catheterization laboratories (ES-others group) and 263 
(15.9%) were transported from the out-of-hospital setting by mobile intensive care units of the OHES 061 
(OHES-061 group). Table 1 shows the baseline characteristics of patients included in the study. 
Table 1. Baseline characteristics of the patients included in the study 
 ES-CHUAC (n=948) ES-others (n=451) OHES-061 (n=263) P 
     
Age, mean (SD), y 64 (12.9) 65.2 (13.6) 62.3 (12.3) .04 
Women, n (%) 192 (20.3) 86 (19.1) 38 (14.4) .1 
Hypertension, n (%) 349 (36.8) 167 (37) 98 (37.3) .99 
Hypercholesterolemia, n (%) 311 (32.8) 120 (26.6) 92 (35) .03 
Diabetes mellitus, n (%) 150 (15.8) 85 (18.8) 40 (15.2) .3 
Smoker or ex-smoker, n (%) 453 (47.8) 184 (40.8) 112 (42.6) .03 
Previous myocardial infarction, n (%) 127 (13.4) 57 (12.6) 18 (6.8) .01 
Previous PCI, n (%) 118 (12.4) 43 (9.5) 19 (7.2) .03 
Previous coronary artery surgery, n (%) 24 (2.5) 11 (2.4) 4 (1.5) .63 
Hemodynamic instability, n (%)a 66 (7) 34 (7.5) 12 (4.6) .28 
Left bundle branch block, n (%) 28 (3) 18 (4) 6 (2.3) .4 
Infarction site, n (%)b    .22 
Anterior/wall 410 (43.2) 199 (44.1) 117 (44.5)  
Inferior/posterior 464 (48.9) 206 (45.7) 133 (50.6)  
Lateral 45 (4.7) 24 (5.3) 6 (2.3)  
Undetermined 29 (3.1) 22 (4.9) 7 (2.7)  
     
 
ES-CHUAC indicates Emergency Services of Complejo Hospitalario Universitario de A Coruña; ES-others, emergency services of 
hospitals lacking catheterization laboratories; OHES-061, out-of-hospital emergency services; PCI, percutaneous coronary 
intervention; SD, standard deviation. 
a Shock of any origin or persistent hypertension requiring infusion of inotropic agents or insertion of an intraaortic balloon co 
unterpulsation device. 
b According to the criteria of the physician who activates the catheterization laboratory 
Prevalence of “False Alarms” 
No culprit coronary lesion was identified in 120 patients (7.2%; 95% confidence interval [CI], 5.9-8.5). 
Of these, 104 (86.7%) received a diagnosis other than STEMI at discharge and 64 (53.3%) tested negative 
for markers of myocardial injury (Figure 1). Thus, the prevalence of patients with an alternative diagnosis 
was 6.3% (95% CI, 5.1-7.4) and the prevalence of patients with no culprit coronary lesion and testing 
negative for markers of myocardial injury was 3.8% (95% CI, 2.9-4.8); 91 patients (5.5%; 95% CI, 4.3-
6.6) were characterized by the absence of significant coronary artery disease. The final diagnoses in 
patients with no culprit lesion are shown in Table 2. 
Of the 1542 patients (92.8%) in whom some type of culprit coronary lesion was identified, 1494 
(89.9%) were treated with primary angioplasty, 12 (0.7%) with coronary revascularization surgery and 36 
(2.2%) received medical treatment. In all, primary angioplasty was not attempted in 168 patients (10.1%; 
95% CI, 8.6-11.6) 
  
 
 
 
Figure 1. Flow chart corresponding to the study. STEMI indicates ST elevation myocardial infarction. 
Table 2. Final diagnoses in the patients with no culprit coronary lesion (n=120)  
Diagnosis Patients, No. 
  
Cardiovascular disease (n=72; 60%) 
STEMI with no culprit coronary lesion 16 
Pericarditis 10 
Transient apical dyskinesia 10 
Coronary spasm 9 
Myocarditis 9 
Aortic dissection 4 
Non-Q-wave myocardial infarction 3 
Severe aortic stenosis 3 
Unstable angina 2 
Pulmonary thromboembolism 1 
Severe aortic insufficiency 1 
Pericardial hematoma 1 
Hypertensive crisis 1 
Idiopathic dilated cardiomyopathy 1 
Cocaine-induced cardiomyopathy 1 
Isolated electrocardiographic changes (n=38; 32%) 
Previous Q-wave infarction 18 
Nonspecific ST segment changes 11 
Left bundle branch block 5 
Early repolarization 1 
Hyperkalemia 1 
Atrioventricular block 1 
Left ventricular hypertrophy 1 
Noncardiovascular disease (n=9; 7%) 
Bacterial pneumonia 3 
Acute cholecystitis 2 
Intestinal ischemia 1 
Cholangitis 1 
Diverticulitis 1 
Esophageal perforation 1 
Unknown (n=1; 1%) 1 
  
 
STEMI indicates ST elevation myocardial infarction. 
  
Clinical Profile and Prognosis of the “False Alarms” 
Patients without a culprit coronary lesion were younger and presented a higher incidence of 
hemodynamic instability and a history of myocardial infarction and previous percutaneous coronary 
intervention than those patients in which a culprit lesion was identified (Table 3). The median time 
interval between the onset of symptoms and coronary angiography was 246 [254] minutes in patients 
without a culprit lesion and 217 [206] minutes in those with a culprit lesion (P=.02). Table 3 shows that 
all the time intervals were longer in the patients without a culprit lesion.  
Table 3. Clinical Features and Time to Coronary Angiography According to the Presence or Absence of a Culprit Coronary Lesion  
 Without Culprit Lesion (n=120) With Culprit Lesion (n=1542) P 
    
Age, mean (SD), y 60.7 (15.2) 63.3 (12.7) .03 
Women, n (%) 30 (25) 286 (18.5) .08 
Hypertension, n (%) 49 (40.8) 565 (36.6) .36 
Hypercholesterolemia, n (%) 39 (32.5) 484 (31.4) .8 
Diabetes mellitus, n (%) 14 (11.7) 261 (16.9) .13 
Smoker or ex-smoker, n (%) 45 (37.5) 704 (45.7) .08 
Previous myocardial infarction, n (%) 31 (25.8) 171 (11.1) <.001 
Previous PCI, n (%) 21 (17.5) 159 (10.3) .01 
Previous coronary artery surgery, n (%) 4 (3.3) 35 (2.3) .46 
Hemodynamic instability, n (%)a 14 (11.7) 98 (6.4) .02 
Left bundle branch block, n (%) 11 (9.2) 41 (2.7) <.001 
Infarction site, n (%)b   <.001 
Anterior/wall 60 (50) 666 (43.2)  
Inferior/posterior 37 (30.8) 766 (49.7)  
Lateral 11 (9.2) 64 (4.2)  
Undetermined 12 (10) 46 (3)  
Delays, min [interquartile range] 
Pain onset to first health care contact 148 [168] 115 [147] .03 
First contact to coronary angiography 122 [95] 90 [72] <.001 
First contact to laboratory activation 49 [55] 25 [38] <.001 
Pain onset to coronary angiography 246 [254] 217 [206] .02 
    
 
PCI indicates percutaneous coronary intervention; SD, standard deviation. 
a Shock of any origin or persistent hypertension requiring infusion of inotropic agents or insertion of an intraaortic balloon 
counterpulsation device. 
b According to the criteria of the physician who activates the catheterization laboratory. 
The 30-day mortality rate was 5.8% (P=.99) in both groups. The causes of death among patients with 
no culprit lesion were septic shock (n=3; pneumonia, cholangitis, and purulent pericarditis secondary to 
esophageal perforation), cardiogenic shock (n=2; severe aortic stenosis and chronic ischemic 
cardiomyopathy), and aortic dissection (n=2). None of these deaths was directly attributable to 
complications of coronary angiography 
Subgroups With a Greater Prevalence of “False Alarms” 
Multivariate analysis revealed a statistically significant association between female sex, age <45 years, 
left bundle branch block, previous myocardial infarction, and activation of the catheterization laboratory 
from emergency services of centers lacking catheterization laboratories with no previous evaluation by a 
cardiologist and the incidence of CLFA (Table 4). The association between the absence of cardiovascular 
risk factors and CLFA was on the borderline of statistical significance (P=.06). The validity of the model 
was corroborated by the Hosmer-Lemeshow goodness-of-fit test (χ2=4.3; P=.74) and by the test for the 
general significance of the coefficients (χ2=49.9; P<.001). The ROC curve of the logistic regression 
model revealed a moderate predictive capacity (AUC=0.67; P<.001). 
  
Table 4.Clinical Factors Associated With absence of a Culprit Coronary Lesion: Multivariate Analysis 
Variable OR (95% CI) P 
   
Age <45 years 2.57 (1.49-4.41) .01 
Woman 1.31 (1.04-2.56) .03 
Previous myocardial infarction 3.11 (1.97-4.9) <.001 
Left bundle branch block 3.46 (1.69-7.11) .01 
Absence of major cardiovascular risk factors a 1.47 (0.99-2.21) .06 
Catheterization laboratory activation modelb  .06 
ES-others 1.64 (1.08-2.5) .02 
OHES-061 1.37 (0.79-2.37) 0.26 
   
 
indicates confidence interval; ES-others, emergency services of hospitals lacking catheterization laboratories; OHES-061, out-of-
hospital emergency services; OR, odds ratio. 
a Absence of a history of hypertension, diabetes mellitus, smoking habit, or dyslipidemia. 
b For this variable, the reference category is the group of patients referred by cardiologists from the emergency service of the 
intervention center. 
Models of Catheterization Laboratory Activation 
The prevalence of an absence of a culprit coronary lesion was significantly higher in the ES-others group 
(9.5%; 95% CI, 7.8-14.4) than in the ES-CHUAC group (6.1%; 95% CI, 4.5-7.7; P=.021), but no 
significant difference was observed between this group and the OHES-061 group (7.2%; 95% CI, 3.9-
10.5; P=.51). The ES-others group had the highest prevalence of patients with a diagnosis other than 
STEMI, with absence of significant coronary artery disease, and with absence of a culprit coronary lesion 
and testing negative for markers of myocardial injury (Figure 2). Considering the ES-CHUAC group as 
the category of reference, the odds ratios (OR) of the absence of a culprit lesion adjusted for the variables 
included in the logistic regression model were OR=1.64 (95% CI, 1.08-2.5) for the ES-others group and 
OR=1.37 (95% CI, 0.79-2.37) for the OHES-061 group (Table 4). 
 
 
 
Figure 2. Prevalence of “false alarms” with three different models of catheterization laboratory activation. ES-CHUAC indicates 
Emergency Services of  
Complejo Hospitalario Universitario de A Coruña; ES-others, emergency services of hospitals lacking catheterization laboratories; 
MIM, myocardial injury markers; NS, not significant; OHES-061, out-of-hospital emergency services; STEMI, ST elevation 
myocardial infarction. 
Discussion 
Prevalence of “False Alarms” 
In this prospective registry of 1662 patients referred for primary angioplasty between January 2003 and 
August 2008, the prevalence of CLFA was 7.2%, based on the criterion of no culprit coronary lesion 
according to the reference coronary angiogram. At the present time, it is understood that the broadening 
of the indications for primary angiography may lead to an increase in the proportion of CLFA, 8 but there 
is a lack of agreement as to what values should be considered unacceptable. The prevalence of CLFA 
observed in our series does not appear to be excessive since it is along the lines of that of other systems 
similar to our setting. The wide variability in the prevalence of CLFA reported in previous studies 
(between 2.3% and 14% 3,5-7 ) reflects regional differences in the quality of the selection systems, but is 
also influenced by the heterogeneity of the criteria for the selection of candidates for primary angioplasty 
and the diversity of the models for diagnosis and prehospital activation of the catheterization laboratory. 
Another circumstance that complicates the comparison of the results from one study to another is the 
use of different criteria to define the CLFA. Despite the fact that the majority of the reports have 
considered only angiographic criteria, the existence of STEMI in the absence of coronary lesions has been 
reported to be a result of mechanisms that include spontaneous coronary recanalization, coronary 
embolism or coronary spasm.9 In our series, 16 patients with no culprit coronary lesion received a 
retrospective diagnosis of STEMI at discharge. If we exclude these cases, the “true” prevalence of CLFA 
(that is, patients with a diagnosis other than STEMI) is reduced to 6.3%. It is interesting to note that 38% 
of the patients in this subgroup tested positive for the markers of myocardial injury, a data that reflects the 
lack of specificity of said determination for the diagnosis of STEMI. It is common to observe an elevation 
of the markers of myocardial injury in patients with myocarditis, pericarditis, congestive heart failure, 
renal failure or sepsis.10 
Clinical Implications 
In order to minimize the delay until reperfusion, the activation of the catheterization laboratory should 
take place as soon after the recognition of the electrocardiographic findings indicating STEMI as possible 
in a patient with symptoms of acute myocardial ischemia, without the aid of other complementary studies 
such as an echocardiogram or markers of myocardial injury. Under these circumstances, the differential 
diagnosis between STEMI and other causes of ST segment elevation11may prove to be difficult. Thus, 
primary angioplasty programs must assume that a certain proportion of CLFA is inevitable, as occurs 
with other procedures in which the delay in therapy is a fundamental prognostic factor (for example, 
emergency laparotomy in patients with suspected appendicitis). 
The activation of the catheterization laboratory is completely justified in most cases of CLFA.12,13 As 
in other studies,5,6 the majority of the CLFA in our series were the consequence of an erroneous 
interpretation of the baseline electrographic changes (such as previous myocardial necrosis, nonspecific 
abnormalities in the ST segment or left bundle branch block) or of confusion with other low risk 
cardiovascular disorders that involve ST segment elevation (pericarditis, myocarditis, transient apical 
dyskinesia). In many of these cases, it is reasonable to perform coronary angiography if doubts 
concerning the diagnosis persist, since the risks associated with the procedure are low13 and usually do not 
surpass the severity of the consequences of not identifying a developing STEMI14 or of administrating 
fibrinolytics to a patient with another disease.15Despite these considerations, we should point out the fact 
that a small proportion of CLFA cases involved patients who presented life-threatening diseases such as 
aortic dissection, septic shock or acute abdominal processes. The severity of this underlying problem 
explains the fact that the 30-day mortality rate was similar to that of the patients with a culprit lesion. 
Recently, Gu et al observed a 30-day mortality rate of 16% in cases of CLFA, and attributed this finding 
to a range of high risk diseases similar to that reported in our study. 
It is precisely in the patients with a severe alteration of their general status in whom we must do our 
utmost to make no mistakes with respect to the diagnosis of STEMI in order to avoid adverse 
consequences derived from a CLFA. Although the majority of these patients benefit from the emergency 
transfer to a tertiary level hospital, the performance of an unnecessary coronary angiogram can have an 
unfavorable prognostic impact in some cases, due both to the increase in the delay until proper treatment 
is provided and to the exposure to the risk of contrast-induced nephropathy and of bleeding in association 
with antithrombotic drugs. Thus, it would appear to be reasonable that the initial diagnostic approach in a 
critically ill patient with inconclusive electrocardiographic findings include the performance of 
noninvasive cardiovascular tests such as echocardiography or computed tomography angiography prior to 
the activation of the catheterization laboratory, although this approach could result in a slight increase in 
the delay to reperfusion in those cases in which the diagnosis of STEMI is ultimately confirmed. 
It is interesting to note that the delay between the onset of symptoms and the first contact with the 
health care system and the interval between the latter and coronary angiography were longer in the cases 
of CLFA than in the patients with STEMI. The explanation for this finding may be the fact that, in the 
cases of CLFA, it is more difficult for the patient to recognize the symptoms and that the physician in 
charge has greater doubts with respect to the suitability of catheterization laboratory activation. 
Groups in Which the Prevalence of “False Alarms” is High 
In our series, we have identified several subgroups of patients with an elevated prevalence of CLFA. One 
of them is made up of individuals under 45 years of age, probably because of their low risk for coronary 
artery disease and the fact that some entities, such as pericarditis, myocarditis and variants of ST segment 
normality, are more common in young patients. CLFA was also more prevalent among women, probably 
in relation to a high frequency of atypical clinical presentation and of transient apical dyskinesia. The 
marked incidence of CLFA among patients with previous myocardial infarction or left bundle branch 
block is explained by the difficulty in interpreting the electrocardiographic findings when there are 
baseline repolarization changes. Given that, in clinical practice, it is difficult to have access to a previous 
tracing with which to compare,6 it may be useful to give a copy of a recent electrocardiogram to all 
patients with cardiovascular disease at the time of their hospital discharge. 
In any case, the analysis of the ROC curve indicates that the capacity of the logistic regression model 
to predict the occurrence of CLFA is low (area under the curve [AUC] =0.67). The wide variability not 
explained by the model indicates the existence of other factors, in many cases circumstantial and difficult 
to measure, that would play a role in the occurrence of a CLFA in routine clinical practice. 
Models for Catheterization Laboratory Activation 
In our study, the prevalence of CLFA in the group of patients referred from emergency services of 
hospitals lacking catheterization laboratories with no previous consultation with a cardiologist was 9.5%. 
This incidence is similar to that reported in previous studies 5,6 and represents an absolute increase of 
3.4% with respect to that observed in the group of patients referred from the emergency service of the 
hospital that is equipped with a catheterization laboratory, where all the cases were evaluated by the 
clinical cardiologist on call prior to catheterization laboratory activation. This finding can be justified in 
part by the greater skill of the cardiologist in interpreting changes in the ST segment,16 but also by his or 
her ability to perform an echocardiogram to support the diagnosis when the electrocardiogram is 
inconclusive. In any case, given that the activation of the catheterization laboratory by emergency 
physicians has made it possible to significantly reduce the door-to-balloon time,17 the slight increase 
observed in the proportion of CLFA does not appear to be enough to justify the systematic evaluation of 
all patients with STEMI by a cardiologist prior to catheterization laboratory activation. This option could 
lead to an unnecessary delay in those patients with conclusive electrocardiographic findings. Thus, we 
consider that it should be reserved exclusively for the uncertain cases.  
The direct transfer of patients with STEMI from the out-of-hospital setting to the catheterization 
laboratory by OHES ambulances is another effective strategy for reducing the door-to-ballon time.18 In 
our study, the activation of the catheterization laboratory by physicians of the mobile intensive care unit 
of the OHES-061 was associated with a low prevalence of CLFA (7.2%), a fact that supports the model 
involving direct transferal as a reasonable option to facilitate the rapid access of patients with an out-of-
hospital diagnosis of STEMI to primary angioplasty. 
Limitations 
The retrospective analysis of the alternative diagnoses has shown that, in some cases, they are purely 
presumptive. Moreover, it could be that the analysis of the influence of the different models of 
catheterization laboratory activation on the prevalence of CLFA is subject to selection bias, given the 
nonrandomized, observational design of the study. For this reason, the results should be considered only 
as a starting point for the generation of hypotheses that will need to be confirmed in future studies. The 
external validity of this analysis is not guaranteed either and, thus, the conclusions may prove to be 
irreproducible in other health care systems. Finally, the lack of information concerning the number of 
patients with STEMI who did not undergo reperfusion therapy has impeded us from analyzing the 
diagnostic sensitivity of the different models of catheterization laboratory activation.   
Conclusions 
In brief, in our series, we have observed a prevalence of CLFA of 7.2% according to the criterion of no 
culprit coronary lesion, which would be reduced to 6.3% if we were to consider only those cases in which 
there was a retrospective diagnosis other than STEMI. Moreover, we have identified a series of factors 
associated with a higher prevalence of CLFA, such as female sex, age less than 45 years, left bundle 
branch block and previous myocardial infarction. Although the majority of the cases of CLFA could be 
attributed to baseline abnormalities in the electrocardiogram or to low risk cardiovascular disease 
(myocarditis, pericarditis, transient apical dyskinesia), a small proportion of patients had some life-
threatening underlying disease (such as aortic dissection, septic shock or acute abdominal processes). 
Finally, our results indicate that the use of different models of catheterization laboratory activation can 
lead to slight variations in the prevalence of CLFA, but they will need to be corroborated in future studies 
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